Lanthanum(III) carbonate hydrate

Name: Lanthanum(III) carbonate hydrate
Brand: ALDRICH
Price: 84 USD
Availability: InStock

99.9% trace metals basis

Synonym(s):

Fosrenol, Lanthanum(3+) tricarbonate hydrate

Slide 1 of 2

Select a Size

100 G

$84.00

Available to ship TODAYDetails

One Time Order

Request a Bulk Order

Subscriptions are currently unavailable.

About This Item

Linear Formula:

La₂(CO₃)₃·xH₂O

CAS Number:

54451-24-0

Molecular Weight:

457.84 (anhydrous basis)

EC Number:

209-599-5

MDL number:

MFCD00149757

UNSPSC Code:

12352302

PubChem Substance ID:

24859532

NACRES:

NA.23

Assay:

99.9% trace metals basis

Form:

powder

Key Documents

View All Documentation

assay

99.9% trace metals basis

form

powder

composition

Degree of hydration, 2-5

reaction suitability

core: lanthanum
reagent type: catalyst

impurities

≤1500.0 ppm Trace Rare Earth Analysis

SMILES string

O.[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O

InChI

1S/3CH2O3.2La.H2O/c3*2-1(3)4;;;/h3*(H2,2,3,4);;;1H2/q;;;2*+3;/p-6

InChI key

AFCUGQOTNCVYSW-UHFFFAOYSA-H

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	211605	238554	447226
Sigma-Aldrich 325767 Lanthanum(III) carbonate hydrate	Sigma-Aldrich 211605 Lanthanum(III) chloride hydrate	Sigma-Aldrich 238554 Lanthanum(III) nitrate hydrate	Sigma-Aldrich 447226 Lanthanum(III) hydroxide
form powder	form powder, crystals or chunks	form (powder, crystals or chunks)	form powder
assay 99.9% trace metals basis	assay 99.9% trace metals basis	assay 99.9% trace metals basis	assay 99.9% trace metals basis
impurities ≤1500.0 ppm Trace Rare Earth Analysis	impurities ≤1500.0 ppm Trace Rare Earth Analysis	impurities ≤2000.0 ppm Trace Rare Earth Analysis	impurities ≤2000.0 ppm Trace Rare Earth Analysis
composition Degree of hydration, 2-5	composition Degree of hydration, ~6	composition Degree of hydration, 3-5	composition -
reaction suitability reagent type: catalyst core: lanthanum	reaction suitability reagent type: catalyst core: lanthanum	reaction suitability reagent type: catalyst core: lanthanum	reaction suitability reagent type: catalyst core: lanthanum

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335

pcodes

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk_germany

nwg

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Regional variance in patterns of prescriptions for chronic kidney disease in Japan.

Reiko Inoue et al.

Clinical and experimental nephrology, 23(6), 859-864 (2019-03-02)

This study aims to describe the regional variance in prescriptions for chronic kidney disease (CKD) medications and to analyze regional characteristics to identify the sources of these differences by utilizing the National Database of Health Insurance Claims, which provides more

Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study.

Stefan P Schumacher et al.

Nephrology (Carlton, Vic.), 24(2), 221-226 (2018-02-27)

Hyperphosphataemia is associated with increased mortality and morbidity in end stage renal disease. Despite phosphate binder therapy, a large proportion of patients do not reach the treatment target. In five contemporary binders we explored the influence of pH and phosphate

PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.

Atsushi Yaguchi et al.

PloS one, 12(7), e0180430-e0180430 (2017-07-14)

The effects of PA21, a novel iron-based and non-calcium-based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease-mineral and bone disorder (CKD-MBD) were evaluated. Rats with adenine-induced chronic renal failure (CRF) were prepared by feeding them

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.

Olivier Phan et al.

BioMed research international, 2015, 515606-515606 (2015-07-30)

Elevated serum phosphorus, calcium, and fibroblast growth factor 23 (FGF23) levels are associated with cardiovascular disease in chronic renal disease. This study evaluated the effects of sucroferric oxyhydroxide (PA21), a new iron-based phosphate binder, versus lanthanum carbonate (La) and sevelamer

Articles

Thermoelectric Performance of Perovskite-type Oxide Materials

The prevailing strategies for heat and electric-power production that rely on fossil and fission fuels are having a negative impact on the environment and on our living conditions.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Lanthanum(III) carbonate hydrate